Cellebrite DI Ltd. - Ordinary Shares (NQ:CLBT)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
More NewsRead More
Earnings Scheduled For November 12, 2025 ↗
November 12, 2025
Via Benzinga
These Fast-Rising Tech Stocks Are Surging in Growth Scores This Week ↗
November 18, 2025
Via Benzinga
Via The Motley Fool
Why Cellebrite Stock Is Skyrocketing Today ↗
November 13, 2025
Via The Motley Fool
12 Information Technology Stocks Moving In Thursday's Intraday Session ↗
November 13, 2025
Via Benzinga
Cellebrite (CLBT) Q3 2025 Earnings Call Transcript ↗
November 13, 2025
Via The Motley Fool
Topics
Earnings
Which stocks are gapping on Thursday? ↗
November 13, 2025
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
November 13, 2025
Via Chartmill
Via Benzinga
Via Benzinga
Via Benzinga
Wednesday's after hours session: top gainers and losers ↗
November 12, 2025
Via Chartmill
Via Benzinga
Cellebrite Announces Third-Quarter 2025 Results
November 12, 2025
From Cellebrite DI Ltd
Via GlobeNewswire
From Cellebrite DI Ltd
Via GlobeNewswire
From Cellebrite DI Ltd
Via GlobeNewswire
Frequently Asked QuestionsIs Cellebrite DI Ltd. - Ordinary Shares publicly traded?
Yes, Cellebrite DI Ltd. - Ordinary Shares is publicly traded.
What exchange does Cellebrite DI Ltd. - Ordinary Shares trade on?
Cellebrite DI Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Cellebrite DI Ltd. - Ordinary Shares?
The ticker symbol for Cellebrite DI Ltd. - Ordinary Shares is CLBT on the Nasdaq Stock Market
What is the current price of Cellebrite DI Ltd. - Ordinary Shares?
The current price of Cellebrite DI Ltd. - Ordinary Shares is 18.27
When was Cellebrite DI Ltd. - Ordinary Shares last traded?
The last trade of Cellebrite DI Ltd. - Ordinary Shares was at 12/05/25 09:51 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>